Dr. Anthony Kwame Enimil

Senior Lecturer


Dept: Child Health
D1 Research Office
Chest clinic

Send quick mail

Research Areas/Interests

He has research interest in pharmacokinetics of antiretrovirals and antiTB medications in HIV/TB co-infected paediatric patients with several publicat...~more

My full CV

Research Projects (Current and Past)

Ongoing Research Support

1R01HD103512-01            Paintsil, E                                             04/2021-03/2026

Pediatric HIV Disclosure Intervention and Benefits Study (PhD-BS)—Sankofa 2

The project will assess the effectiveness, health benefits, cost and implementation of a novel pediatric HIV disclosure intervention (“Sankofa”) among dyads of caregivers and children 7-18 years of age (who do not know their HIV diagnosis) in Ghana

Role: Co-Investigator

 

 

R01 HD071779   Kwara (PI)                                                                                           01/2019-12/2023

Pharmacokinetics of Anti-Tuberculosis and Antiretrovirals in children.

The study has three arms: Anti-TB, Efavirenz, and TDF/FTC/EFV. It is postulated that children are under-dosed. This study aims to measure the actual concentration of the drug in children aged 3 months to 14 years.

Role: Co-Principal Investigator

 

5K23MH114632-03                                                           Tarantino (PI)                                                    07/2020-06/2023

Text Based Adherence Game

The current project aims to develop and evaluate a novel mobile health (mHealth) gaming intervention tailored specifically for young people to promote their adherence to HIV care

 

Completed Research Support

Lifespan/Tufts/Brown    CFAR Enimil (PI)                07/2017-10/2019

Improving Adolescent Engagement in Care Through Group-Based Economic Incentives

The goal of this study was to investigate the use of group based economic incentives on adherence to HIV treatment among adolescents living with HIV.

Role: Principal Investigator

 

R01 HD071779     Kwara (PI)                                                                                            09/2013-08/2017

Pharmacokinetics of Anti-Tuberculosis and Antiretrovirals in children.

The study has three arms: Anti-TB, Efavirenz, and TDF/FTC/EFV. It is postulated that children are under-dosed. This study aims to measure the actual concentration of the drug in children aged 3 months to 14 years.

Role: Co-Principal Investigator

 

R01 HD074253                                   Paintsil, Reynolds (MPIs)                                              03/2013-06/2017

A bioecological paediatric HIV disclosure intervention in Ghana (Sankofa)

This study looked at disclosure of HIV status issues in children living with HIV.

Role: Co-Investigator

 

STOPTB-GHANA                Enimil (PI)                                                                           12/2015-04/2017

T5 CONCEPT (TREAT, TRACT, TRAP, TAME childhood TB)

This study identified children with sputum positive TB and tracked them into the community for contact tracing and treatment.

Role: Principal Investigator

 

Lifespan/Tufts/Brown    CFAR                     Barker (PI)                                          11/2014-11/2015

Improving Adolescent HIV Treatment Adherence Through Use of Peer-Led Adherence Teams

The goal of this study was to investigate the forming of peer groups among adolescents reporting for routine care on HIV treatment adherence.

Role: International Principal Investigator

 

Lifespan/Tufts/Brown CFAR                        Norman (PI)                       01/2013-12/2014

Psychosocial influence and its impact on clinical outcome in HIV infected adolescents in Kumasi, Ghana: a pilot study

This study assessed the association between psychosocial factors and clinical outcomes in adolescents living with HIV in Ghana.

Role: Co-Principal Investigator

 


Print page

SEND QUICK MAIL TO STAFF

Subject

Message

Your Email Address:
Note: this is to help the staff contact you back.